Karnani Vikram
SEC insider (Form 3/4/5 filer). CIK 0001699488. President and CEO at COLLEGIUM PHARMACEUTICAL, INC (COLL) and 1 other issuer. 6 reported Form 4/5 transactions since Sep 2024; latest on Feb 10, 2026. Located in STOUGHTON, MA.
Companies Karnani Vikram has filed insider reports for
- COLLEGIUM PHARMACEUTICAL, INC (COLL): Director, Officer, President and CEO
- Dyne Therapeutics, Inc. (DYN): Director
Karnani Vikram
CIK: 0001699488
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (6 total)
- Feb 10, 2026COLL
COLLEGIUM PHARMACEUTICAL, INC
AwardDirect79.3K shares- - Feb 10, 2026COLL
COLLEGIUM PHARMACEUTICAL, INC
AwardDirect32.5K shares- - Feb 10, 2026COLL
COLLEGIUM PHARMACEUTICAL, INC
Tax PaymentDirect11.3K shares at avg. $46.75$528K - Dec 22, 2025DYN
Dyne Therapeutics, Inc.
AwardDirectStock option (right to buy)
59.7K shares- - Nov 12, 2025COLL
COLLEGIUM PHARMACEUTICAL, INC
Tax PaymentDirect9K shares at avg. $47.35$425K - Nov 12, 2024COLL
COLLEGIUM PHARMACEUTICAL, INC
AwardDirect106K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Feb 10, 2026 |  COLL COLLEGIUM PHARMACEUTICAL, INC | Award | 79,264 | - | $0 | Direct |
| Feb 10, 2026 | COLL COLLEGIUM PHARMACEUTICAL, INC | Award | 32,531 | - | $0 | Direct |
| Feb 10, 2026 | COLL COLLEGIUM PHARMACEUTICAL, INC | Tax Payment | 11,296 | $46.75 | $528,088 | Direct |
| Dec 22, 2025 |  DYN Dyne Therapeutics, Inc. | Award Stock option (right to buy) | 59,665 | - | - | Direct |
| Nov 12, 2025 | COLL COLLEGIUM PHARMACEUTICAL, INC | Tax Payment | 8,983 | $47.35 | $425,345 | Direct |
| Nov 12, 2024 | COLL COLLEGIUM PHARMACEUTICAL, INC | Award | 105,972 | - | $0 | Direct |
1-6 of 6 transactions